Home›Companies›Biotech & Pharma›Bascule Biosciences

Bascule Biosciences, Inc.

No website or LinkedIn page we could confirm. Why?
Updated Nov 10, 2026·Latest SEC filing Apr 2, 2026·Suggest an edit

About Bascule Biosciences

Bascule Biosciences is a private company based in New Rochelle, New York, incorporated in 2026 in Delaware. It has reported $250,000 raised in one offering on Form D since April 2026. Its chief executive is Aafia Chaudhry.

Funding Rounds (SEC Form D)

First saleFiled with SECAmount soldInvestorsAvg. checkTermsFiling
Mar 25, 2026Apr 2, 2026$250,000fully sold1$250KOptions, SAFERule 506(b)Form D ↗

First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.

Leadership Team

Executive officers and directors listed on Bascule Biosciences's Form D filed Apr 2, 2026.

AC
Aafia Chaudhry
Chief Executive Officer and director

Sources

  1. SECBascule Biosciences, Inc. filing history